Galaxy Medicare, listed on NSE SME, filed a non-applicability certificate for the Reg 27(2) corporate governance report for the quarter ended 30 September 2026. The exemption, as an SME-platform entity, carries no financial or business impact.
Galaxy Medicare Limited held its 34th Annual General Meeting on September 28, 2026. Shareholders approved all agenda items, including the adoption of financial statements and dividend declaration.
Galaxy Medicare Limited has fixed September 11, 2026, as the record date for determining shareholder entitlement to the final dividend for the 2025-26 financial year.
Galaxy Medicare Limited submitted a Working Capital Certificate and corrected a clerical error regarding paid-up equity share capital in its XBRL filing.
Galaxy Medicare Limited filed a compliance report. The company stated that corporate governance reporting requirements for SME platforms are not applicable.
Galaxy Medicare Limited recommended a final dividend of ₹0.35 per equity share. The record date and general meeting for shareholder approval will be announced separately.
Galaxy Medicare Limited re-appointed Saroj Ray & Associates as Secretarial Auditor for a twelve-month term. The decision ensures continued regulatory compliance and governance oversight.
Galaxy Medicare Limited approved FY2026 audited results and recommended a Rs.0.35 dividend per share. The board also re-appointed the Managing Director and Whole Time Director.
Galaxy Medicare approved the re-appointment of Dillip Kumar Das as Managing Director and Subhasish Das as Whole Time Director. These leadership extensions ensure management continuity.
Galaxy Medicare reported audited full-year FY26 revenue of ₹40.00 Crore and a ₹3.42 Crore net profit. The board also recommended a ₹0.35 per share dividend.